Senators question Allergan CEO on tribe patent deal

A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.

Alex Levine, Author at School of Pharmacy

Selling Sovereignty: How Corporations Used Tribal Sovereign Immunity to Evade Regulation and Exploit Consumers - The Flaw

Ed Silverman - STAT - Page 218 of 299

Supreme Court case could deal a blow to Mohawk tribe's patent plan

Prescription Drug Costs

Notes Archives – Page 4 of 28 – Southern California Law Review

Patent Move Was 'Nuts,' Regeneron CEO Tells Allergan Chief - Bloomberg

U.S. Senators Press Allergan for Details on Patent Deal With Tribe

All eyes on Saint Regis Mohawk Tribe in contentious patent case

CONTROVERSIAL STRATEGY: SELLING PATENTS TO A NATIVE AMERICAN TRIBE